Update to living systematic review on drug treatments for covid-19

BMJ. 2021 Mar 31:372:n858. doi: 10.1136/bmj.n858.
No abstract available

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Anticoagulants / therapeutic use
  • Antiparasitic Agents / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Humans
  • Interleukin-6 / antagonists & inhibitors
  • Janus Kinase Inhibitors / therapeutic use
  • Pharmaceutical Preparations / supply & distribution*
  • Respiration, Artificial / statistics & numerical data
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / genetics
  • Systematic Reviews as Topic

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Antiparasitic Agents
  • Antirheumatic Agents
  • Antiviral Agents
  • Interleukin-6
  • Janus Kinase Inhibitors
  • Pharmaceutical Preparations